Novartis Pharmaceuticals Corp Company Profile

Aggregated data from the web about Novartis Pharmaceuticals Corp

Company Name	Novartis Pharmaceuticals Corp
Website	https://www.novartis.us
Snippet	Novartis Pharmaceuticals Corporation researches, develops, manufactures & markets innovative prescription drug treatments for diseases and conditions.
ISIN	CH0012005267
Type	Aktiengesellschaft
Founded	1996, (from merger)
Revenue	US$51.900 billion (2018)[2]
Website	Novartis.com
Founders	Johann RudolfAlexander Clavel
Industry	Pharmaceuticals
Products	Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
Traded as	SIX: NOVN, NYSE: NVS
Key people	Vasant Narasimhan (CEO)[1]
Net income	US$12.614 billion (2018)[2]
Area served	Worldwide
Predecessor	Ciba-Geigy, Sandoz (via merger)
Headquarters	Basel, Switzerland
Total assets	US$145.563 billion (2018)[2]
Total equity	US$78.692 billion (2018)[2]
Operating income	US$8.169 billion (2018)[2]
Number of employees	125,161[2] (2017)

Novartis Pharmaceuticals Corp is part of the Switzerland company list

Novartis Pharmaceuticals Corp is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.